 |
|
| Blog results | Results 1 - 10 of about 2,914 for hormone refractory prostate cancer. (1.01 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | The Prostate Cancer Blog - http://cancer.healthdiaries.com/prostate/ Advanced Prostate Cancer - http://advancedprostatecancer.net/ THE "NEW" PROSTATE CANCER INFOLINK - http://prostatecancerinfolink.net/ | |
| 8 Oct 2009 Men with metastatic hormone-refractory prostate cancer are needed to participate in a research trial. DukeHealth.org: Duke Clinical Trials - http://www.dukehealth.org/?utm_source=dukehealth.org&utm_m... [ More results from DukeHealth.org: Duke Clinical Trials ] |
| 7 hours ago The Company is also conducting separate Phase 2 trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant (hormone-refractory) prostate cancer. Additionally, Poniard has completed a ... Stock market news - Company News - 4-Traders.com - http://www.4-traders.com/news/latest/ |
| 20 Nov 2009 by Sitemaster ... Dendreon that the company can expect a ruling on the approval of sipuleucel-T (Provenge), the company's investigational immunotherapeutic agent for the treatment of hormone-refractory prostate cancer, on or before May 1, 2010. ... THE "NEW" PROSTATE CANCER INFOLINK - http://prostatecancerinfolink.net/ [ More results from THE "NEW" PROSTATE CANCER INFOLINK ] |
| 11 Nov 2009 by Joel A chart review performed at the Department of Internal Medicine, University of Alberta, Edmonton, AB. concluded that the a quick rate of initial PSA decline in men with hormone refractory prostate cancer receiving docetaxel chemotherapy ... Advanced Prostate Cancer - http://advancedprostatecancer.net/ [ More results from Advanced Prostate Cancer ] |
| 28 Oct 2009 by Jim Tucker URO TODAY: A combination of docetaxel/zoledronic/prednisone in chemotherapy for hormone refractory prostate cancer patients is safe and effective, say Indian researchers. For patients with a Gleason score less than 7, PSA declined more ... Prostablog - http://prostablog.wordpress.com/ [ More results from Prostablog ] |
| 14 Oct 2009 by Alaoui-Jamali, MA, Bismar, TA, Gupta, A.,... A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate Cancer. Moulay A. Alaoui-Jamali1, Tarek A. Bismar2, Ajay Gupta3, Walter A. Szarek4, Jie Su1, Wei Song1, Yingjie Xu1, Bin Xu1, Guoan Liu1, ... Cancer Research current issue - http://cancerres.aacrjournals.org/ [ More results from Cancer Research current issue ] |
| 20 Nov 2009 by Markho Rafael A Japanese article from 2004 reported a “dramatic remission of hormone refractory prostate cancer achieved with extract of the mushroom, Phellinus linteus.” [15]. 2. Next out was a Korean article published in 2005, which reported on a ... Mapping Your News - http://mapping-news.com/ |
| 1 May 2008 by Berthold, DR, Pond, GR, Roessner, M., de... Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study ... Clinical Cancer Research recent issues - http://clincancerres.aacrjournals.org/ - References [ More results from Clinical Cancer Research recent issues ] |
| 28 Aug 2009 by jacquie strax ZD4054 is a potential anti-cancer agent now in a clinical trials around the world for men with metastatic hormone refractory prostate cancer (HRPC) and for men with non-metastatic hormone refractory prostate cancer. ... PSA Rising Prostate Cancer Blog - http://psa-rising.com/blog/ - References [ More results from PSA Rising Prostate Cancer Blog ] |
| 16 Nov 2009 There are currently no approved treatments for end-stage (hormone and chemotherapy refractory) prostate cancer and the survival time is estimated to be between 8 and 12 months. About Hollis-Eden Pharmaceuticals ... Pharmaceutical Online Downloads - http://www.pharmaceuticalonline.com/ [ More results from Pharmaceutical Online Downloads ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
